From April 1, 2012 to June 30, 2012, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 37,530,000 shares, representing 1.64% for $2,293.58 million under the buyback announced on December 15, 2010.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
97.32 CHF | +0.73% | +0.41% | +14.43% |
05/07 | Novo Nordisk Reprimanded in UK Over Undisclosed Payments; Novartis, Pfizer Found in Breach of Industry Code | MT |
05/07 | UK Pharmaceutical Trade Group Slams Novartis, Three Others for Breaches | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.43% | 22TCr | |
+56.89% | 82TCr | |
+40.61% | 63TCr | |
-6.55% | 35TCr | |
+15.99% | 32TCr | |
+7.92% | 30TCr | |
+14.11% | 24TCr | |
-0.41% | 22TCr | |
+7.94% | 17TCr | |
-2.57% | 16TCr |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- Tranche Update on Novartis AG's Equity Buyback Plan announced on December 15, 2010.